Trial
NCT04459286
The Nitazoxanide Plus Atazanavir for COVID-19 Study
Phase IITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Obafemi Awolowo University
Collaborators
University of Liverpool; African Centre of Excellence for Genomics of Infectious Diseases; Infectious Disease Hospital Olodo; Obafemi Awolowo University Teaching Hospital; Osun State Ministry of Health; Olabisi Onabanjo University Teaching Hospital
Condition
Covid-19
Intervention
Nitazoxanide and atazanavir/ritonavir
Why stopped
IDSMB recommendation
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-02